BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2224129)

  • 1. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.
    Saglio G; Guerrasio A; Rosso C; Zaccaria A; Tassinari A; Serra A; Rege-Cambrin G; Mazza U; Gavosto F
    Blood; 1990 Nov; 76(9):1819-24. PubMed ID: 2224129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia.
    Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K
    Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal breakpoints within the first intron of the ABL gene are nonrandom in patients with chronic myelogenous leukemia.
    Jiang XY; Trujillo JM; Liang JC
    Blood; 1990 Aug; 76(3):597-601. PubMed ID: 2198962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
    Mills KI; Sproul AM; Burnett AK
    Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia.
    Wilson G; Frost L; Goodeve A; Vandenberghe E; Peake I; Reilly J
    Blood; 1997 Apr; 89(8):3064. PubMed ID: 9108430
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL rearrangements in children with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Aurer I; Butturini A; Gale RP
    Blood; 1991 Nov; 78(9):2407-10. PubMed ID: 1932752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
    Melo JV; Gordon DE; Cross NC; Goldman JM
    Blood; 1993 Jan; 81(1):158-65. PubMed ID: 8417787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.
    Suryanarayan K; Hunger SP; Kohler S; Carroll AJ; Crist W; Link MP; Cleary ML
    Blood; 1991 Jan; 77(2):324-30. PubMed ID: 1985699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
    Campbell ML; Li W; Arlinghaus RB
    Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.
    Chissoe SL; Bodenteich A; Wang YF; Wang YP; Burian D; Clifton SW; Crabtree J; Freeman A; Iyer K; Jian L
    Genomics; 1995 May; 27(1):67-82. PubMed ID: 7665185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ
    Rev Invest Clin; 2004; 56(5):605-8. PubMed ID: 15776864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
    Akashi K; Taniguchi S; Nagafuji K; Harada M; Shibuya T; Hayashi S; Gondo H; Niho Y
    Leuk Res; 1993 Jul; 17(7):549-55. PubMed ID: 8326735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
    Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
    Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization.
    Tkachuk DC; Westbrook CA; Andreeff M; Donlon TA; Cleary ML; Suryanarayan K; Homge M; Redner A; Gray J; Pinkel D
    Science; 1990 Oct; 250(4980):559-62. PubMed ID: 2237408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
    Saussele S; Weisser A; Müller MC; Emgi M; La Rosée P; Paschka P; Kuhn C; Willer A; Hehlmann R; Hochhaus A
    Leukemia; 2000 Nov; 14(11):2006-10. PubMed ID: 11069038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.
    Melo JV; Gordon DE; Tuszynski A; Dhut S; Young BD; Goldman JM
    Blood; 1993 May; 81(10):2488-91. PubMed ID: 8490164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
    Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F
    Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.